HRP980108B1 - Atropisomers of 3-heteroaryl-4 (3h)-quinazolinones - Google Patents

Atropisomers of 3-heteroaryl-4 (3h)-quinazolinones

Info

Publication number
HRP980108B1
HRP980108B1 HR980108A HRP980108A HRP980108B1 HR P980108 B1 HRP980108 B1 HR P980108B1 HR 980108 A HR980108 A HR 980108A HR P980108 A HRP980108 A HR P980108A HR P980108 B1 HRP980108 B1 HR P980108B1
Authority
HR
Croatia
Prior art keywords
quinazolinones
atropisomers
heteroaryl
Prior art date
Application number
HR980108A
Other languages
English (en)
Inventor
Willard Mckowan Welch
Bertrand Leo Chenard
Keith Michael Devries
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HRP980108A2 publication Critical patent/HRP980108A2/hr
Publication of HRP980108B1 publication Critical patent/HRP980108B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR980108A 1997-02-28 1998-02-27 Atropisomers of 3-heteroaryl-4 (3h)-quinazolinones HRP980108B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3854097P 1997-02-28 1997-02-28

Publications (2)

Publication Number Publication Date
HRP980108A2 HRP980108A2 (en) 1998-12-31
HRP980108B1 true HRP980108B1 (en) 2004-10-31

Family

ID=21900535

Family Applications (1)

Application Number Title Priority Date Filing Date
HR980108A HRP980108B1 (en) 1997-02-28 1998-02-27 Atropisomers of 3-heteroaryl-4 (3h)-quinazolinones

Country Status (40)

Country Link
US (1) US6380204B1 (fr)
EP (1) EP0964860B1 (fr)
JP (1) JP3299990B2 (fr)
KR (1) KR20000075812A (fr)
CN (1) CN1248254A (fr)
AP (1) AP9801202A0 (fr)
AR (1) AR011886A1 (fr)
AT (1) ATE264854T1 (fr)
AU (1) AU732448B2 (fr)
BG (1) BG103687A (fr)
BR (1) BR9807807A (fr)
CA (1) CA2282279C (fr)
CO (1) CO4950615A1 (fr)
DE (1) DE69823339T2 (fr)
DK (1) DK0964860T3 (fr)
DZ (1) DZ2438A1 (fr)
EA (1) EA001961B1 (fr)
ES (1) ES2218801T3 (fr)
GT (1) GT199800039A (fr)
HN (1) HN1998000028A (fr)
HR (1) HRP980108B1 (fr)
HU (1) HUP0000935A3 (fr)
ID (1) ID23435A (fr)
IL (1) IL130897A0 (fr)
IS (1) IS5141A (fr)
MA (1) MA24485A1 (fr)
NO (1) NO994178L (fr)
NZ (1) NZ336627A (fr)
OA (1) OA11088A (fr)
PA (1) PA8446901A1 (fr)
PE (1) PE57999A1 (fr)
PL (1) PL335307A1 (fr)
PT (1) PT964860E (fr)
SK (1) SK113199A3 (fr)
TN (1) TNSN98034A1 (fr)
TR (1) TR199902094T2 (fr)
TW (1) TW530055B (fr)
UA (1) UA58536C2 (fr)
WO (1) WO1998038187A1 (fr)
ZA (1) ZA981665B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323208B1 (en) * 1997-09-05 2001-11-27 Pfizer Inc Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones
JPH11279158A (ja) * 1998-02-09 1999-10-12 Pfizer Prod Inc キナゾリン―4―オン誘導体の製造方法
US6890930B1 (en) * 1999-09-28 2005-05-10 3-Dimensional Pharmaceuticals, Inc. Quinazolinones
US20080146562A1 (en) * 2003-08-08 2008-06-19 Ulysses Pharmaceutical Products Inc., Halogenated quinazolinyl nitrofurans as antibacterial agents
EP1660486A4 (fr) * 2003-08-08 2006-12-13 Ulysses Pharmaceutical Product Quinazolinyl nitrofuranes halogenes utilises comme agents antibacteriens
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
GB0507298D0 (en) 2005-04-11 2005-05-18 Novartis Ag Organic compounds
EP1954283A2 (fr) * 2005-11-04 2008-08-13 Hydra Biosciences, Inc. Composés destinés à moduler la fonction de trpv3
CA2663436A1 (fr) * 2006-10-04 2008-04-10 Pfizer Products Inc. Derives de pyrido[4,3-d]pyrimidin-4(3h)-one utilises en tant qu'antagonistes du recepteur calcique
WO2008140750A1 (fr) 2007-05-10 2008-11-20 Hydra Biosciences Inc. Composés modulant la fonction du trp v3
CA2756347A1 (fr) * 2009-03-24 2010-09-30 Gilead Calistoga Llc Atropisomeres de derives de 2-purinyl-3-tolyl-quinazolinone et procedes d'utilisation
EP2435048B1 (fr) * 2009-05-29 2019-07-03 Merck Sharp & Dohme Corp. Inhibiteurs de pde10 radio-marqués
WO2013105985A1 (fr) * 2011-02-28 2013-07-18 Philadelphia Health & Education Corporation Inhibiteurs à petites molécules de la recombinase rad51 et procédés associés
WO2021154966A1 (fr) 2020-01-29 2021-08-05 Kamari Pharma Ltd. Composés et compositions pour leur utilisation dans le traitement de troubles cutanés

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1298603A (en) 1970-04-06 1972-12-06 Karamchand Premchand Private Quinazolinone derivatives
US4183931A (en) 1977-09-08 1980-01-15 Research Corporation 2-Ketoalkyl-4(3H)-quinazolinones
WO1992013535A1 (fr) 1991-02-06 1992-08-20 Research Corporation Technologies, Inc. Quinazolones substituees a activite anticonvulsivante
PT901487E (pt) 1996-05-15 2003-08-29 Pfizer 4(3h)-quinazolinonas 2,3,6-trissubstituidas
EP0807633B1 (fr) * 1996-05-15 2002-11-06 Pfizer Inc. (5,6)-Pyrimidin-4-ones condensées à hétéroaryle, substituées en 2,3

Also Published As

Publication number Publication date
CA2282279A1 (fr) 1998-09-03
OA11088A (en) 2002-03-15
HN1998000028A (es) 1999-02-09
HUP0000935A2 (hu) 2001-04-28
ID23435A (id) 2000-04-20
AU5775998A (en) 1998-09-18
BR9807807A (pt) 2000-02-22
NZ336627A (en) 2000-12-22
NO994178D0 (no) 1999-08-27
JP2000509732A (ja) 2000-08-02
EA001961B1 (ru) 2001-10-22
DK0964860T3 (da) 2004-07-26
DE69823339T2 (de) 2005-05-12
MA24485A1 (fr) 1998-10-01
TNSN98034A1 (fr) 2005-03-15
AP9801202A0 (en) 1999-08-26
CO4950615A1 (es) 2000-09-01
US6380204B1 (en) 2002-04-30
PL335307A1 (en) 2000-04-10
CA2282279C (fr) 2004-11-02
WO1998038187A1 (fr) 1998-09-03
PE57999A1 (es) 1999-06-21
AR011886A1 (es) 2000-09-13
GT199800039A (es) 1999-08-13
EP0964860B1 (fr) 2004-04-21
PA8446901A1 (es) 2000-05-24
IL130897A0 (en) 2001-01-28
KR20000075812A (ko) 2000-12-26
ES2218801T3 (es) 2004-11-16
IS5141A (is) 1999-07-30
HRP980108A2 (en) 1998-12-31
TR199902094T2 (xx) 1999-12-21
DE69823339D1 (de) 2004-05-27
JP3299990B2 (ja) 2002-07-08
UA58536C2 (uk) 2003-08-15
BG103687A (en) 2000-06-30
HUP0000935A3 (en) 2002-04-29
CN1248254A (zh) 2000-03-22
DZ2438A1 (fr) 2003-01-11
ATE264854T1 (de) 2004-05-15
TW530055B (en) 2003-05-01
SK113199A3 (en) 2001-10-08
AU732448B2 (en) 2001-04-26
NO994178L (no) 1999-08-27
PT964860E (pt) 2004-07-30
EP0964860A1 (fr) 1999-12-22
ZA981665B (en) 1999-08-17
EA199900689A1 (ru) 2000-02-28

Similar Documents

Publication Publication Date Title
ZA981666B (en) Atropisomers of 3-aryl-4(3H)-quinazolinones.
PL337442A1 (en) Expression adjustment of quinolane phosphoribozyltransferase
EG24291A (en) Novel form of s-omeprazole
PL323066A1 (en) Derivatives of quinazoline
PL313541A1 (en) Derivatives of quinazoline
ZA981665B (en) Atropisomers of 3-heteroaryl-4(3H)-quinazolinones.
ZA985326B (en) Aminospiropiperidine quinazoline derivatives
TW317091U (en) Structure improvement of hats
EP1143998A4 (fr) Traitement de l'hypertension
PL327430A1 (en) Set of shaped components
TW312301U (en) Improved structure of earmask
TW319017U (en) Improved structure of mousetraps
GB9721978D0 (en) Treatment of depression
TW409833U (en) Improvement of burner structure
TW357554U (en) Improvement of shinguards
TW314733U (en) Structure of hairclip
TW316466U (en) Structure of hangtag
TW332992U (en) Improved structure of earring
TW393958U (en) Structural improvement of chair
TW312131U (en) Improved structure of earflaps
TW317745U (en) Improved structure of mini-duster
TW323471U (en) Improved structure of hairclip
TW358333U (en) Improvement of pendant structure
GB9708700D0 (en) Treatment of depression
HU9802548D0 (en) Set of tiles

Legal Events

Date Code Title Description
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
A1OB Publication of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040812

Year of fee payment: 7

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20050228